Author(s): Becquement L, Alfrieve A, Amstutz U, Brauch H, Jacqz-Algrain E, Laurent-Puig P, Molina MA, Niemi M, Schwab M, Somogyi AA, Thervet E, Maitland-van der Zee AH, van Kuilenburg ABP, van Schaik RHN, Verstuyft C, Wadelius M, Daly AK
Keywords: adverse drug reaction azathioprine cetuximab clopidogrel gefitinib genetic testing pharmacogenetics statins tacrolimus tamoxifen warfarin METASTATIC COLORECTAL-CANCER DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY CELL LUNG-CANCER BREAST-CANCER SLCO1B1 POLYMORPHISM GENETIC-DETERMINANTS SEVERE TOXICITY TAMOXIFEN CYP2D6 PHARMACOKINETICS
|
Professor Ann Daly
|
|